Stock WELL WELL HEALTH TECHNOLOGIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials WELL Health Technologies Corp.

Equities

WELL

CA94947L1022

Healthcare Facilities & Services

Market Closed - Toronto S.E.
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.59 CAD +0.28% Intraday chart for WELL Health Technologies Corp. +1.99% -6.75%
Apr. 18 WELL Health Maintained at Buy at Stifel GMP as it Buys 10 Clinics From Shoppers Drug Mart; Price Target Kept at C$11.00 MT
Apr. 17 WELL Health Technologies Rises 3%, TD Says Shopper Drug Mart Deal Likely For "Low Price" MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 179.6 1,307 1,022 653.6 929.5 882.5 - -
Enterprise Value (EV) 1 168.7 1,307 1,297 898 1,231 1,119 1,106 1,036
P/E ratio -19.5 x -268 x -21.3 x - - -36.8 x -718 x 35.9 x
Yield - - - - - - - -
Capitalization / Revenue 5.48 x 26 x 3.38 x 1.15 x 1.2 x 0.92 x 0.85 x 0.81 x
EV / Revenue 5.14 x 26 x 4.29 x 1.58 x 1.59 x 1.17 x 1.07 x 0.95 x
EV / EBITDA -98.5 x -14,209 x 21.5 x 8.59 x 10.9 x 8.79 x 7.36 x 6.47 x
EV / FCF - -201 x 66.2 x 12.8 x 21.1 x 15.3 x 11.8 x 13 x
FCF Yield - -0.5% 1.51% 7.81% 4.74% 6.55% 8.5% 7.71%
Price to Book 0.05 x - - - - - - -
Nbr of stocks (in thousands) 115,159 162,404 208,166 230,153 241,428 245,808 - -
Reference price 2 1.560 8.050 4.910 2.840 3.850 3.590 3.590 3.590
Announcement Date 3/31/20 3/18/21 3/31/22 3/21/23 3/21/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 32.81 50.24 302.3 569.1 776.1 956.7 1,038 1,092
EBITDA 1 -1.713 -0.092 60.36 104.6 113.4 127.2 150.3 160.2
EBIT 1 -6.086 -10.41 -12.79 23.31 - 46.52 77.37 122.2
Operating Margin -18.55% -20.71% -4.23% 4.1% - 4.86% 7.45% 11.19%
Earnings before Tax (EBT) 1 -7.759 -6.986 -24.97 17.92 - 5.391 41.06 81.7
Net income 1 -7.819 -3.686 -43.79 1.369 - -20.79 0.9887 25
Net margin -23.83% -7.34% -14.48% 0.24% - -2.17% 0.1% 2.29%
EPS 2 -0.0800 -0.0300 -0.2300 - - -0.0975 -0.005000 0.1000
Free Cash Flow 1 - -6.517 19.59 70.14 58.33 73.3 94 79.8
FCF margin - -12.97% 6.48% 12.32% 7.52% 7.66% 9.06% 7.31%
FCF Conversion (EBITDA) - - 32.45% 67.08% 51.44% 57.61% 62.54% 49.83%
FCF Conversion (Net income) - - - 5,123.59% - - 9,507.62% 319.2%
Dividend per Share - - - - - - - -
Announcement Date 3/31/20 3/18/21 3/31/22 3/21/23 3/21/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 99.29 115.7 126.5 140.3 145.8 156.5 169.4 170.9 204.5 231.2 227.3 235 241.2 252.1 250.4
EBITDA 1 22.28 25.68 23.49 26.43 27.46 27.17 26.68 27.79 28.17 30.75 27.52 30.65 32.83 36.12 34.35
EBIT 1 -2.856 6.848 7.374 6.324 8.578 2.288 8.759 10.11 7.079 - 6.769 11.04 13.07 15.61 15.42
Operating Margin -2.88% 5.92% 5.83% 4.51% 5.88% 1.46% 5.17% 5.91% 3.46% - 2.98% 4.7% 5.42% 6.19% 6.16%
Earnings before Tax (EBT) 1 -9.486 2.287 -0.039 -3.025 3.785 18.36 -10.44 -0.127 -4.507 - -3.492 0.614 1.778 6.491 9.7
Net income 1 -12.34 -8.803 -8.019 -5.903 -4.419 20.63 -14.36 -5.767 -7.606 - -8.459 -5.434 -4.793 -2.069 -0.5145
Net margin -12.43% -7.61% -6.34% -4.21% -3.03% 13.18% -8.47% -3.37% -3.72% - -3.72% -2.31% -1.99% -0.82% -0.21%
EPS 2 -0.0600 -0.0400 -0.0400 -0.0300 -0.0200 0.0900 -0.0600 -0.0300 -0.0300 - -0.0375 -0.0225 -0.0200 -0.0100 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/10/21 3/31/22 5/11/22 8/11/22 11/10/22 3/21/23 5/12/23 8/10/23 11/14/23 3/21/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 275 244 302 236 224 153
Net Cash position 1 10.9 - - - - - - -
Leverage (Debt/EBITDA) - - 4.549 x 2.337 x 2.66 x 1.858 x 1.488 x 0.956 x
Free Cash Flow 1 - -6.52 19.6 70.1 58.3 73.3 94 79.8
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 33.00 - - - - - - -
Cash Flow per Share -0.0300 -0.0400 - - - - - -
Capex 1 0.47 1.13 2.68 6.4 8.11 8.85 9.09 9.2
Capex / Sales 1.44% 2.26% 0.89% 1.13% 1.04% 0.92% 0.88% 0.84%
Announcement Date 3/31/20 3/18/21 3/31/22 3/21/23 3/21/24 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for WELL Health Technologies Corp.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
3.59 CAD
Average target price
7.453 CAD
Spread / Average Target
+107.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
WELL HEALTH TECHNOLOGIES CORP. Stock WELL Health Technologies Corp.
-6.75% 645M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. WELL Stock
  4. Financials WELL Health Technologies Corp.